Coya Therapeutics (NASDAQ:COYA – Get Free Report) is one of 974 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Coya Therapeutics to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, profitability, institutional ownership and risk. Volatility & Risk Coya Therapeutics […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report) is one of 975 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its rivals? We will compare Coya Therapeutics to related businesses based on the strength of its profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Analyst Ratings This is a […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report) and Spero Therapeutics (NASDAQ:SPRO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Volatility and Risk Coya Therapeutics has a […]
Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 31,700 shares, a growth of 41.5% from the November 30th total of 22,400 shares. Based on an average trading volume of 46,700 shares, the days-to-cover ratio […]
Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 59,300 shares, a growth of 78.6% from the September 30th total of 33,200 shares. Currently, 0.7% of the company’s shares are sold short. […]